You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Details for Patent: 10,646,436


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,646,436 protect, and when does it expire?

Patent 10,646,436 protects EYSUVIS and is included in one NDA.

This patent has sixty-five patent family members in twelve countries.

Summary for Patent: 10,646,436
Title:Compositions and methods for ophthalmic and/or other applications
Abstract: Particles, compositions, and methods that aid particle transport in mucus are provided. The particles, compositions, and methods may be used, in some instances, for ophthalmic and/or other applications. In some embodiments, the compositions and methods may involve modifying the surface coatings of particles, such as particles of pharmaceutical agents that have a low aqueous solubility. Such compositions and methods can be used to achieve efficient transport of particles of pharmaceutical agents though mucus barriers in the body for a wide spectrum of applications, including drug delivery, imaging, and diagnostic applications. In certain embodiments, a pharmaceutical composition including such particles is well-suited for ophthalmic applications, and may be used for delivering pharmaceutical agents to the front of the eye and/or the back of the eye.
Inventor(s): Popov; Alexey (Waltham, MA), Enlow; Elizabeth M. (Waltham, MA), Chen; Hongming (Belmont, MA), Bourassa; James (Somerville, MA)
Assignee: The Johns Hopkins University (Baltimore, MD)
Application Number:15/977,911
Patent Claim Types:
see list of patent claims
Use; Composition; Process; Dosage form;
Patent landscape, scope, and claims:

United States Patent 10,646,436: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

The United States Patent 10,646,436, titled "Compositions and methods for ophthalmic and/or other applications," is a significant patent in the field of pharmaceuticals, particularly focusing on ophthalmic treatments. This article will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Scope of the Patent

Overview of the Invention

The patent describes pharmaceutical compositions that include a plurality of coated particles. Each particle consists of a core particle containing loteprednol etabonate, a corticosteroid, and a coating layer. This design is intended to enhance the delivery and efficacy of the drug, particularly for ophthalmic applications[1].

Key Components

  • Core Particle: The core particle is composed of loteprednol etabonate, which is a potent corticosteroid used to treat various eye conditions such as inflammation and allergic reactions.
  • Coating Layer: The coating layer is crucial for controlling the release of the drug, ensuring sustained delivery and minimizing side effects.

Claims of the Patent

Independent Claims

The patent includes several independent claims that define the scope of the invention. These claims cover:

  • Pharmaceutical Composition: The composition comprising coated particles with a core of loteprednol etabonate and a coating layer.
  • Methods of Preparation: Methods for preparing these coated particles, including specific steps and materials used.
  • Methods of Use: Methods for using these compositions in ophthalmic and other medical applications[1].

Dependent Claims

Dependent claims further specify the details of the independent claims, such as the materials used for the coating layer, the size and shape of the particles, and specific conditions for the preparation and use of the compositions.

Patent Landscape Analysis

Definition and Importance

Patent landscape analysis, also known as patent mapping, is a comprehensive process that analyzes and organizes vast amounts of patent data to extract valuable insights. This analysis helps in understanding the competitive landscape, identifying trends, and making informed business decisions[3].

Legal Status and Expiry Dates

The legal status of the patent (US10646436B2) is active, indicating that it is currently enforceable. Understanding the expected expiry dates of patents is crucial for planning future strategies, including potential licensing or development of similar technologies[3].

Market Developments and Trends

  • Competitor Analysis: Patent landscape analysis reveals competitors in the field of ophthalmic pharmaceuticals. Companies like Bausch + Lomb and Allergan have significant patents in this area, indicating a competitive market.
  • Mergers and Acquisitions: Recent mergers and acquisitions in the pharmaceutical industry can impact the patent landscape. For example, the acquisition of smaller companies by larger pharmaceutical firms can consolidate patent portfolios.
  • Litigation and Opposition Activities: Tracking litigation and opposition activities related to similar patents helps in understanding potential legal challenges and opportunities for collaboration or licensing[3].

Technological Trends

The use of coated particles and specific corticosteroids like loteprednol etabonate is a trending technology in ophthalmic treatments. This trend is reflected in the increasing number of patents filed in this area, indicating a growing interest in advanced drug delivery systems.

Global Patent Landscape

International Patent Offices

To fully understand the patent landscape, it is essential to search for similar patents in other countries. Databases such as the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO) provide access to international patent data. This helps in identifying global competitors and potential licensing opportunities[4].

Common Citation Document (CCD)

The CCD application consolidates prior art cited by multiple patent offices, providing a comprehensive view of the global patent landscape for a specific invention. This tool is particularly useful for understanding the international scope of similar patents[4].

Practical Applications and Benefits

Enhanced Drug Delivery

The coated particles described in the patent offer improved drug delivery, reducing the frequency of administration and minimizing side effects. This is particularly beneficial in ophthalmic treatments where patient compliance is crucial.

Market Opportunities

Understanding the patent landscape around this invention can help companies identify market gaps and opportunities. For instance, developing similar compositions for other medical applications could expand market share.

Challenges and Limitations

Regulatory Compliance

Compliance with regulatory requirements is a significant challenge. Ensuring that the pharmaceutical composition meets all regulatory standards, both in the U.S. and internationally, is essential for market approval.

Competition

The ophthalmic pharmaceutical market is highly competitive. Companies must navigate through existing patents and develop strategies to differentiate their products while avoiding infringement.

Key Takeaways

  • Innovative Drug Delivery: The patent introduces an innovative method of drug delivery using coated particles, enhancing the efficacy and safety of loteprednol etabonate.
  • Comprehensive Patent Landscape: Understanding the patent landscape is crucial for identifying competitors, trends, and market opportunities.
  • Global Considerations: International patent searches and analyses are necessary to fully grasp the global implications of the invention.
  • Regulatory and Competitive Challenges: Navigating regulatory requirements and competitive landscapes is essential for successful market entry.

FAQs

What is the main component of the pharmaceutical composition described in US Patent 10,646,436?

The main component is loteprednol etabonate, a corticosteroid, which is encapsulated in coated particles.

What is the purpose of the coating layer in the pharmaceutical composition?

The coating layer controls the release of the drug, ensuring sustained delivery and minimizing side effects.

How does patent landscape analysis help in understanding the competitive landscape?

Patent landscape analysis provides insights into competitors, market trends, mergers and acquisitions, and litigation activities, helping companies make informed business decisions.

Where can one find international patent data to understand the global patent landscape?

International patent data can be found through databases such as the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO).

What are the potential market opportunities for the pharmaceutical composition described in the patent?

The composition could be developed for other medical applications beyond ophthalmic treatments, expanding market share and addressing unmet medical needs.

Sources

  1. US10646436B2 - Compositions and methods for ophthalmic and/or other applications - Google Patents
  2. US-20080306039-A1 - Unified Patents Portal
  3. Navigating Technological Domains with Patent Landscape Analysis - Sagacious Research
  4. Search for patents - USPTO - United States Patent and Trademark Office

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,646,436

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Alcon Labs Inc EYSUVIS loteprednol etabonate SUSPENSION/DROPS;OPHTHALMIC 210933-001 Oct 26, 2020 RX Yes Yes 10,646,436 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,646,436

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2013256064 ⤷  Subscribe
Australia 2013256092 ⤷  Subscribe
Australia 2014342097 ⤷  Subscribe
Australia 2018201215 ⤷  Subscribe
Australia 2018202074 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.